Literature DB >> 17638655

Pigmented purpuric dermatosis: classification by phenotypic and molecular profiles.

Cynthia M Magro1, Jochen T Schaefer, A Neil Crowson, Jingwei Li, Carl Morrison.   

Abstract

The categorization of pigmented purpuric dermatosis (PPD) as a form of cutaneous lymphoid dyscrasia has been suggested. Phenotypic and molecular studies were done on 43 patients with PPD. The molecular studies used a capillary gel electrophoresis T-cell receptor beta multiplex polymerase chain reaction assay. There were 2 principal categories: polyclonal PPD represented by 22 cases and monoclonal variants comprising 21 cases. Monoclonal cases had extensive skin lesions. An identical restricted T-cell repertoire independent of time and location was observed. Approximately 40% of the monoclonal cases had clinical and pathologic features of mycosis fungoides (MF). In the polyclonal variant, disease outside the lower extremities was uncommon; there were no patients with MF. Striking reductions in CD7 and CD62L were seen in both groups. PPD is a form of cutaneous T-cell lymphoid dyscrasia, based on the frequency of monoclonality, the preservation of persistent T-cell clonotypes, and extent of pan-T-cell marker loss. Stratification of lesions of PPD according to the molecular profile may be of significant value prognostically and influence therapeutic intervention.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17638655     DOI: 10.1309/AQMU3JFE2A66LC7E

Source DB:  PubMed          Journal:  Am J Clin Pathol        ISSN: 0002-9173            Impact factor:   2.493


  7 in total

1.  Characteristics and Clinical Manifestations of Pigmented Purpuric Dermatosis.

Authors:  Dai Hyun Kim; Soo Hong Seo; Hyo Hyun Ahn; Young Chul Kye; Jae Eun Choi
Journal:  Ann Dermatol       Date:  2015-07-29       Impact factor: 1.444

2.  TNF-α inhibitor induced pigmented purpuric dermatoses: a case report.

Authors:  Divita Jhaveri; Frances Zhao
Journal:  BMC Rheumatol       Date:  2022-04-29

3.  Clinical and laboratory findings of pigmented purpuric dermatoses.

Authors:  Müzeyyen Gönül; Seray Külcü Çakmak; Nimet Ozcan; Işıl Deniz Oğuz; Ulker Gül; Zeynep Bıyıklı
Journal:  Ann Dermatol       Date:  2014-09-26       Impact factor: 1.444

4.  Successful Topical Treatment of Pigmented Purpuric Lichenoid Dermatitis of Gougerot-Blum in a Young Patient: A Case Report and Summary of the Most Common Pigmented Purpuric Dermatoses.

Authors:  Jeyanthini Risikesan; Mette Sommerlund; Mette Ramsing; Mattias Kristensen; Uffe Koppelhus
Journal:  Case Rep Dermatol       Date:  2017-09-15

5.  Scaly erythematous papules and plaques in a teenager.

Authors:  Antonio Jimenez; Paige Hoyer; Michael Wilkerson
Journal:  JAAD Case Rep       Date:  2021-02-04

6.  Venous Insufficiency is a Clear Provoker of Pigmented Purpuric Dermatosis.

Authors:  Hak-Jun Kim; Gi-Wook Lee; Jin-Wha Son; Kihyuk Shin; Hoon-Soo Kim; Hyun-Chang Ko; Byung-Soo Kim; Moon-Bum Kim
Journal:  Ann Dermatol       Date:  2022-01-27       Impact factor: 1.444

7.  Targetoid clinical morphology as a diagnostic clue of the lichenoid histopathologic subtype of pigmented purpuric dermatosis.

Authors:  Amara Ahmed; Tyler Werbel; Anna De Benedetto; Kiran Motaparthi
Journal:  JAAD Case Rep       Date:  2021-05-26
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.